Hosted on MSN1mon
ResMed Inc. stock falls Friday, underperforms marketResMed Inc. closed 10.21% short of its 52-week ... Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet.
With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, manufacturing, and distributing medical devices and cloud-based software ...
ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...
ResMed Inc. (NYSE:RMD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen ratings firms that are covering the company, Marketbeat.com reports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results